Related Articles
Prospective replication study implicates the catechol-O-methyltransferase Val158Met polymorphism as a biomarker for the response to morphine in patients with cancer
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain
Efficacy and tolerability of oxycodone in moderate-severe cancer‑related pain: Α meta‑analysis of randomized controlled trials
Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients
Effect of systemic injection of heterogenous and homogenous opioids on peripheral cellular immune response in rats with bone cancer pain: A comparative study